Matt Martin Matt Martin

Precision Health Reports Announced as a Semi-Finalist in the NC IDEAS Fall 2020 SEED Grant Cycle

Precision Health Reports was among the 23 semi-finalist selectees selected from 131 submissions for the NC IDEA Foundation Fall 2020 SEED Grant Cycle.

Semi-Finalists Seeking $50,000 Each in NC IDEA’s 30th SEED Grant Cycle

 DURHAM, NC – September 28, 2020 – NC IDEA, a private foundation committed to supporting entrepreneurial ambition and economic empowerment in North Carolina, announced today that the organization has selected 23 semi-finalists from across the state in its 30th SEED grant cycle. These semi-finalists were chosen from 131 competitive applications received by the organization.

“Even thirty cycles in, it’s still a difficult task narrowing down a competitive field of demographically and geographically diverse applicants,” said Thom Ruhe, President and CEO of NC IDEA. “We look forward to learning more about the group moving forward in the next phase of the process.”

The 23 Fall 2020 NC IDEA SEED Semi-Finalists include:

The semi-finalists have been invited to submit a full proposal with greater details by early October. Finalists will then be selected to present before a review panel comprised of experienced investors, industry experts and entrepreneurs. Grant recipients will be announced in mid-November. The $50,000 grants are intended to support business activities that validate target markets, reduce risk associated with early stage companies and help companies get to the point of suitability for growth; whether through investment or revenue.

About NC IDEA FOUNDATION: NC IDEA is an independent private foundation committed to empowering North Carolinians to achieve their entrepreneurial potential. Through our powerful combination of competitive grants and programs, and a network of strategic partners, we help entrepreneurs when they need it most. NC IDEA’s resources are highly competitive, enabling the foundation to support North Carolina’s most ambitious entrepreneurs. We believe entrepreneurs transform communities and view our work as a catalyst for positive change. Learn more at www.ncidea.org.

About Precision Health Reports, Inc: Precision Health Reports was founded in April 2020 to provide a digital health diagnostics tool that address individual cardiometabolic risk. Our mission is to give healthcare providers tools that allow them to address individual risks earlier in the disease cycle and enable them to prevent the progression to costly and deadly diabetes, heart attack, or stroke.

Read More
News Matt Martin News Matt Martin

Precision Health Reports raises $300,000 in pre-seed funding for new digital health diagnostics products

Little Rock and Raleigh-based company is bringing a new metabolic health analysis to help health professional identify individual’s diabetic risks

Precision Health Reports, a new digital health diagnostics company, raised $300k in pre-seed convertible note funding to launch their new Diabetic Risk Assessment product into a new SaaS platform. These new diagnostic tools enable physicians, dietitians, and health coaches to accurately identify and manage individual risk for developing type 2 diabetes. 

“With diabetes and cardiovascular disease being significant comorbidities contributing to the severity of the current COVID-19 pandemic, we felt the urgency to rapidly make these analyses available to our clients nationwide,” explains Matthew Martin, CEO of Precision Health Reports. “We are honored that we were able to bring together angel investors, including several physicians and seasoned business professionals, that understand the value that we are bringing with these effective diagnostic tools.”

Martin and cofounder Dr. William Cromwell, M.D., Chief Medical Officer for Precision Health Reports, started Precision Health Reports to make individual risk analysis for metabolic and cardiovascular disease more accurate, faster, and to arm care providers and individuals with the proper insights to develop a tailored plan for early intervention. Cardiovascular disease is the #1 leading cause of death in the U.S. with type 2 diabetes being the 7th leading cause of death. These two devastating diseases cost over $500B in direct healthcare costs annually to treat.

Dr. William Cromwell, M.D., Chief Medical Officer for Precision Health Reports explained, “Diabetes, heart attacks, and stroke are metabolically linked by a complex array of risk factors that together constitute a person’s global cardiometabolic risk. Integrating global cardiometabolic risk factors with appropriate clinical guidelines allows providers to develop a highly personalized treatment plan, as well as follow individual response to therapy so that therapy can be adjusted to optimize reduction in diabetes, heart attack, and stroke risk.”

Individual risk assessments from Precision Health Reports integrate personal medical information, outcome-proven biomarkers, and evidence-based guidelines that uniquely discriminate individual risk for cardiometabolic diseases. Clients using these risk assessments are able to tailor individual therapy plans to reduce a person’s risks of diabetes and cardiovascular events then track the individual’s response to their prescribed treatment plan.

 

-----------

Precision Health Reports was founded in April 2020 to provide a digital health diagnostics tool that address individual cardiometabolic risk.

Read More